Negocios · 11/1/20231 min de lectura
Advisory Committee; Cardiovascular and Renal Drugs Advisory Committee; Renewal; Correction
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration is correcting a notice entitled "Advisory Committee; Cardiovascular and Renal Drugs Advisory Committee; Renewal" that appeared in the Federal Register of December 13, 2022. The document announced the renewal of the Cardiovascular and Renal Drugs Advisory Committee. The document was published with the incorrect docket number. This document corrects that error.